Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow 27 August 2026

  • August 26, 2026
  • Posted by: Kunal Singla
  • Category: Predictions
No Comments

Nifty Pharma: 26,626.30 (+0.23%). High 26,764.95. Low 26,437.15. VIX 10.56. Support 26,450.00. Resistance 26,575.00. No F&O expiry Thu 27 Aug.

Quick Answer

The tomorrow’s Nifty Pharma outlook for 27 August 2026 is positive with immediate support at 26,450.00 and resistance at 26,575.00. Nifty Pharma closed at 26,626.30 on Thursday, 26 August, +0.23% from the previous close. Thursday is a post-expiry session with no F&O settlement, making the Thursday’s pharma session more momentum-driven. Ankit Jaiswal of Univest recommends watching 26,450.00 as the critical hold level for the pharma index Wednesday forecast on 27 August 2026.

The Nifty Pharma Wednesday outlook for 27 August 2026 is shaped by a mixed Wednesday session where banking stocks led while IT and FMCG lagged. Nifty Pharma closed at 26,626.30, +0.23 percent, as the broader market saw Bank Nifty surging 0.47 percent to 57,783.75 while Nifty 50 closed at its day low of 24,207.75. India VIX fell to 10.56. Nifty Pharma was the best-performing Nifty sector on Thursday, gaining 0.85 percent. Sun Pharmaceutical Industries rose 0.63 percent and Dr Reddys Laboratories added 0.29 percent. The index closed at its intraday high of 26,574. The tomorrow’s Nifty Pharma outlook benefits from Thursday’s post-expiry clean slate, as no Nifty or Bank Nifty F&O settlement will distort price discovery.

Ankit Jaiswal, equity research analyst at Univest, notes that the Thursday’s pharma session is supported by the Nifty’s bullish candle on Thursday. A Nifty that closes at its day high typically sees follow-through buying in sectoral indices on the next session. This statistical bias supports the pharma index Wednesday forecast for Wednesday.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Nifty Pharma Performance on 26 August 2026
  • Nifty Pharma Wednesday outlook: Technical Analysis
  • Nifty Pharma Support and Resistance for 27 August 2026
  • Key Stocks Driving Nifty Pharma Wednesday outlook
  • Global and Domestic Factors for Nifty Pharma Prediction for Tomorrow
  • Risks to the Nifty Pharma Prediction for Tomorrow
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow on 27 August 2026?
    • What is the key support for the nifty pharma prediction for tomorrow?
    • What resistance should traders watch for the nifty pharma prediction for tomorrow?
    • How does Nifty 50’s bullish close affect the nifty pharma prediction for tomorrow?
    • Which stocks will drive the nifty pharma prediction for tomorrow?

Nifty Pharma Performance on 26 August 2026

Metric Value
Index Close 26,626.30
Change +62.30 (+0.23%)
Day High 26,764.95
Day Low 26,437.15
Previous Close 26,564.00
India VIX 10.56 (-4.69%)

Nifty Pharma Wednesday outlook: Technical Analysis

The tomorrow’s Nifty Pharma outlook is anchored by Thursday’s session structure. The index held above its 50-day moving average zone, which remains a constructive signal for the Thursday’s pharma session. RSI in the 50-58 range following Tuesday’s close suggests the beginning of a momentum phase. The pharma index Wednesday forecast becomes bullish above 26,575.00 and bearish below 26,450.00 on a 15-minute NSE chart close for Wednesday.

Nifty Pharma Support and Resistance for 27 August 2026

  • Support 1: 26,450.00. Thursday’s session floor zone. The Nifty Pharma Wednesday outlook stays constructive above this level on Thursday.
  • Support 2: 26,215.00. Stronger base. A breach here would materially weaken the tomorrow’s Nifty Pharma outlook.
  • Resistance 1: 26,575.00. Tuesday’s intraday high zone. The Thursday’s pharma session turns bullish above this level.
  • Resistance 2: 26,750.00. Upper resistance. A close above upgrades the pharma index Wednesday forecast significantly.

Key Stocks Driving Nifty Pharma Wednesday outlook

Key stocks driving the tomorrow’s Nifty Pharma outlook for 27 August 2026 include Sun Pharmaceutical Industries, Dr Reddys Laboratories, HDFC Bank, Reliance Industries, and ICICI Bank. Their individual performance on Thursday will determine whether the Thursday’s pharma session outperforms or underperforms the Nifty 50 benchmark.

Screen Nifty Pharma constituent stocks on Univest Screener for Wednesday

Global and Domestic Factors for Nifty Pharma Prediction for Tomorrow

The pharma index Wednesday forecast for Thursday is shaped by GIFT Nifty futures and overnight global cues. Nifty 50 closing at its day high on Thursday means GIFT Nifty is likely positive overnight, which is a direct tailwind for the nifty pharma prediction for tomorrow. FII provisional data for 25 August indicated mild net buying, and any continuation on Thursday would strengthen the nifty pharma prediction for tomorrow further toward the 26,575.00 resistance.

Domestically, Thursday’s absence of any F&O expiry means the nifty pharma prediction for tomorrow will trade on genuine institutional conviction rather than expiry-driven positioning. This makes the nifty pharma prediction for tomorrow support and resistance levels more reliable for Wednesday than they would be on an expiry day.

Download the Univest iOS App or Univest Android App to track the nifty pharma prediction for tomorrow with live NSE index data for Wednesday.

Risks to the Nifty Pharma Prediction for Tomorrow

  • A negative GIFT Nifty opening that causes the broader market to gap down, dragging Nifty Pharma below 26,450.00 and invalidating the nifty pharma prediction for tomorrow.
  • FII net selling on Thursday reversing Tuesday’s provisional buying and pressuring Nifty Pharma below the nifty pharma prediction for tomorrow support zone.
  • India VIX spiking above 12 on Thursday, signalling unexpected market stress that contradicts the calm nifty pharma prediction for tomorrow framework.
  • Sector-specific negative news released after Tuesday’s market close that affects key Nifty Pharma constituents and alters the nifty pharma prediction for tomorrow materially.

Conclusion

The nifty pharma prediction for tomorrow for 27 August 2026 is positive with Nifty Pharma at 26,626.30 and immediate support at 26,450.00. A hold above this level on Thursday keeps the nifty pharma prediction for tomorrow constructive. Ankit Jaiswal at Univest recommends watching the first 15-minute candle of Thursday’s session to confirm the nifty pharma prediction for tomorrow direction before committing to positions. GIFT Nifty before 9:15 AM IST will be the earliest signal for whether the nifty pharma prediction for tomorrow will follow through on Thursday’s positive momentum on 27 August 2026.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. This information is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow on 27 August 2026?

Ans. The nifty pharma prediction for tomorrow is positive for 27 August 2026. Nifty Pharma closed at 26,626.30 on 26 August, +0.23%. Support is at 26,450.00 and resistance at 26,575.00. Thursday is a post-expiry session with no Nifty or Bank Nifty F&O settlement, allowing cleaner directional price discovery for the nifty pharma prediction for tomorrow.

What is the key support for the nifty pharma prediction for tomorrow?

Ans. The nifty pharma prediction for tomorrow places immediate support at 26,450.00, based on Thursday’s session floor. Secondary support is at 26,215.00. A hold above 26,450.00 on Thursday keeps the nifty pharma prediction for tomorrow constructive.

What resistance should traders watch for the nifty pharma prediction for tomorrow?

Ans. The nifty pharma prediction for tomorrow places first resistance at 26,575.00, near Tuesday’s intraday high. Upper resistance is at 26,750.00. A sustained close above 26,575.00 would upgrade the nifty pharma prediction for tomorrow to bullish for 27 August 2026.

How does Nifty 50’s bullish close affect the nifty pharma prediction for tomorrow?

Ans. Bank Nifty closed at 57,783.75 (+0.47%) even as Nifty 50 fell to 24,207.75 (-0.52%) on 26 August with VIX at 10.56. The banking sector strength on Wednesday supports the nifty pharma prediction for tomorrow for Thursday, as broad market confidence typically lifts sector indices. India VIX at 10.56 also confirms reduced market stress ahead of the nifty pharma prediction for tomorrow session.

Which stocks will drive the nifty pharma prediction for tomorrow?

Ans. Sun Pharmaceutical Industries, Dr Reddys Laboratories, HDFC Bank are among the key stocks that will drive the nifty pharma prediction for tomorrow for 27 August 2026. Their performance relative to the Nifty 50 trend on Thursday will determine if the nifty pharma prediction for tomorrow outperforms or underperforms the benchmark.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply